Our study provides the first evidence that RPRM, a potential p53-dependent tumor suppressor gene, is frequently hypermethylated in ERα-positive breast tumor types, probably due to the effect of E2/ERα in the recruitment of methylation components. The gene discussed is TP53; the disease is breast neoplasm.